KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Cost of Revenue (2016 - 2026)

Medtronic's Cost of Revenue history spans 13 years, with the latest figure at $3.3 billion for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 17.34% to $3.3 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $12.5 billion, a 8.15% increase, with the full-year FY2025 number at $11.6 billion, up 3.71% from a year prior.
  • Cost of Revenue hit $3.3 billion in Q1 2026 for Medtronic, up from $3.1 billion in the prior quarter.
  • Over the last five years, Cost of Revenue for MDT hit a ceiling of $3.3 billion in Q1 2026 and a floor of $2.5 billion in Q1 2022.
  • Historically, Cost of Revenue has averaged $2.8 billion across 5 years, with a median of $2.8 billion in 2025.
  • Biggest five-year swings in Cost of Revenue: fell 6.18% in 2022 and later increased 17.34% in 2026.
  • Tracing MDT's Cost of Revenue over 5 years: stood at $2.5 billion in 2022, then grew by 8.92% to $2.8 billion in 2023, then grew by 6.7% to $2.9 billion in 2024, then increased by 3.9% to $3.1 billion in 2025, then rose by 6.53% to $3.3 billion in 2026.
  • Business Quant data shows Cost of Revenue for MDT at $3.3 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.0 billion in Q3 2025.